Physician

Anastassia Amaro, MD

According to 2025 Medicare claims, Anastassia Amaro, MD (NPI: 1013134659) practices endocrinology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1477658599; TIN: 232743545) and primary practice location at 19104-5127.

Amaro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 158 traditional Medicare patients, billed 435 HCPCS/CPT codes, and received $21,319 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,248 prescription claims across 200 beneficiaries totaling $932,363 in drug costs, led by Ozempic (Semaglutide). DME data shows 282 claims. Open Payments data shows 5 records totaling $4,884. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $557,514 to $932,363. For DME billing, reported payments rose steadily, from $951 to $75,924.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	276	461	$33,388
2016	253	370	$26,514
2017	195	290	$19,616
2018	218	296	$22,837
2019	206	279	$21,103
2020	206	350	$24,506
2021	167	317	$23,916
2022	165	304	$20,983
2023	181	320	$24,113
2024	158	435	$21,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	205	1,609	$557,514
2016	212	1,474	$566,135
2017	222	1,312	$583,307
2018	208	1,121	$594,909
2019	234	1,338	$761,687
2020	243	1,598	$995,531
2021	205	1,419	$1,018,005
2022	177	1,203	$964,409
2023	213	1,271	$1,120,737
2024	200	1,248	$932,363

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	142	350	$6,741
2016	132	281	$5,449
2017	83	181	$3,220
2018	74	191	$8,118
2019	66	177	$15,756
2020	110	385	$58,059
2021	134	531	$83,778
2022	74	343	$47,579
2023	62	313	$50,783
2024	75	282	$72,913

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	17	21	$111
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	17	17	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	106	142	$73
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	46	56	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	123	161	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	221	9,878	$308,306
Mounjaro	Tirzepatide	161	6,614	$233,538
Trulicity	Dulaglutide	67	3,136	$104,084
Jardiance	Empagliflozin	57	3,931	$72,328
Humulin R U-500 Kwikpen	Insulin Regular, Human	17	850	$29,640

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	36	189	$63,847
E0784	External ambulatory infusion pump, insulin	Y	N/R	17	$5,787
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	12	12	$2,460
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	44	$790
A4259	Lancets, per box of 100	N	11	20	$29

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$1,484	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$3,400	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anastassia Amaro, MD?

Tedicare shows public-source Medicare data for Anastassia Amaro, MD (NPI 1013134659), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anastassia Amaro, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anastassia Amaro, MD?

Anastassia Amaro, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1477658599) in the available physician profile data.

Does Anastassia Amaro, MD have Open Payments data?

Anastassia Amaro, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.